October 11, 2023
October 11, 2023 —
University of California San Diego cancer biologist Tatiana Hurtado de Mendoza has been named the recipient of the 2023 Claugus Award for Medical Research. The award was established in 2021 by the Foundation For A Better World.
October 5, 2022
October 5, 2022 —
UC San Diego researchers discover that quality and mix of protein in a type of pancreatic cancer is the determinant of whether the prognosis is poor or very poor.
June 28, 2023
June 28, 2023 —
UC San Diego researchers find a combination of drugs outperformed other treatments in human and mouse models of pancreatic cancer; now urge clinical trial
April 15, 2021
April 15, 2021 —
Moores Cancer Center at UC San Diego Health is among the few clinical trial sites in the U.S. for the Pancreatic Cancer Action Network’s (PanCAN) newly created Precision Promise, the first large-scale precision medicine trial designed to transform outcomes for patients with pancreatic cancer.
May 1, 2015
May 1, 2015 —
…temporal relationship between gastrointestinal stromal tumors (GIST) and other cancers. The results, published by Cancer on April 30, indicate that one in 5.8 patients with GIST will develop additional malignancies before and after their diagnosis.
March 21, 2022
March 21, 2022 —
UC San Diego study finds new screening tool flags 95 percent of stage 1 pancreatic cancers.
January 17, 2023
January 17, 2023 —
UC San Diego scientists discover a molecular pathway critical to the initiation of pancreatic tumors. The findings may inspire new chemotherapeutic drugs targeting early stages of tumor formation and spread
January 19, 2023
January 19, 2023 —
UC San Diego researchers describe how pancreatic cancer stem cells leverage a protein in a family of proteins that normally suppress tumors to instead do the opposite, boosting their resistance to conventional treatments and spurring growth.
September 13, 2017
September 13, 2017 —
In a new study, published this month in Cancer Discovery, University of California San Diego School of Medicine researchers report that approximately half of lung and pancreatic cancers that originate with a KRAS mutation become addicted to the gene as they progress.
May 17, 2018
May 17, 2018 —
…test to screen for pancreatic cancer in a drop of blood. New Blood Test Rapidly Detects Signs of Pancreatic Cancer Pancreatic cancer is expected to become the second deadliest cancer in the United States by 2030. It is tough to cure because it is usually not discovered until it has…